Tags

Type your tag names separated by a space and hit enter

[Information about phosphorus additives and nutritional counseling].
Clin Calcium. 2012 Oct; 22(10):1583-91.CC

Abstract

Hyperphosphatemia is a common disorder in patients with chronic kidney disease (CKD) , and may result in hyperparathyroidism and renal osteodystrophy. Hyperphosphatemia also may contribute to deterioration vascular calcification and increase mortality. Hence, correction and prevention of hyperphosphatemia is a main component of the management of CKD. This goal is usually approached both by administering phosphorus binders and by restricting dietary phosphorus (P) intake. Dietary intake of phosphorus (P) is derived largely from foods with high protein content or food additives and is an important determinant of P balance in patient with CKD. Food additives (PO4) can dramatically increase the amount of P consumed in the daily diet, especially because P is more readily absorbed in its inorganic form. In addition, information about the P content and type in prepared foods is often unavailable or misleading. Therefore, during dietary counseling of patients with CKD, we recommended that they consider both the absolute dietary P content and the P-to-protein ratio of foods and meals including food additives.

Authors+Show Affiliations

Department of Molecular Nutrition, University of Tokushima Graduate School, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

23023640

Citation

Kido, Shinsuke, et al. "[Information About Phosphorus Additives and Nutritional Counseling]." Clinical Calcium, vol. 22, no. 10, 2012, pp. 1583-91.
Kido S, Nomura K, Sasaki S, et al. [Information about phosphorus additives and nutritional counseling]. Clin Calcium. 2012;22(10):1583-91.
Kido, S., Nomura, K., Sasaki, S., Shiozaki, Y., Segawa, H., & Tatsumi, S. (2012). [Information about phosphorus additives and nutritional counseling]. Clinical Calcium, 22(10), 1583-91.
Kido S, et al. [Information About Phosphorus Additives and Nutritional Counseling]. Clin Calcium. 2012;22(10):1583-91. PubMed PMID: 23023640.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Information about phosphorus additives and nutritional counseling]. AU - Kido,Shinsuke, AU - Nomura,Kengo, AU - Sasaki,Shohei, AU - Shiozaki,Yuji, AU - Segawa,Hiroko, AU - Tatsumi,Sawako, PY - 2012/10/2/entrez PY - 2012/10/2/pubmed PY - 2013/3/21/medline SP - 1583 EP - 91 JF - Clinical calcium JO - Clin Calcium VL - 22 IS - 10 N2 - Hyperphosphatemia is a common disorder in patients with chronic kidney disease (CKD) , and may result in hyperparathyroidism and renal osteodystrophy. Hyperphosphatemia also may contribute to deterioration vascular calcification and increase mortality. Hence, correction and prevention of hyperphosphatemia is a main component of the management of CKD. This goal is usually approached both by administering phosphorus binders and by restricting dietary phosphorus (P) intake. Dietary intake of phosphorus (P) is derived largely from foods with high protein content or food additives and is an important determinant of P balance in patient with CKD. Food additives (PO4) can dramatically increase the amount of P consumed in the daily diet, especially because P is more readily absorbed in its inorganic form. In addition, information about the P content and type in prepared foods is often unavailable or misleading. Therefore, during dietary counseling of patients with CKD, we recommended that they consider both the absolute dietary P content and the P-to-protein ratio of foods and meals including food additives. SN - 0917-5857 UR - https://www.unboundmedicine.com/medline/citation/23023640/[Information_about_phosphorus_additives_and_nutritional_counseling]_ DB - PRIME DP - Unbound Medicine ER -